Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation
- 4 June 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 14 (3), 123-130
- https://doi.org/10.1177/1078155208090624
Abstract
Background. Cancer patients take medications for coexisting disease and self-medicate with over-the-counter drugs (OTCs). A complete analysis of the use of prescription drugs, OTCs, and supplements during cancer treatment has never been done.Methods. The study developed and validated a self-administered questionnaire on the use of concomitant medications by patients undergoing treatment with chemotherapy. The questionnaire listed 510 prescription medications, OTCs, and supplements (including vitamins, minerals, and herbs). Fifty-two subjects completed the questionnaire while visiting the infusion clinic to receive chemotherapy. On a subsequent visit the subjects brought their medications to the clinic and a pharmacist reviewed their completed questionnaire.Results. Ninety-six percent of the subjects reported taking prescription medications within 3 days prior to chemotherapy, 71% reported taking OTCs and 69% reported use of supplements. The subjects took an average of 5.5 (range 0—13) prescription drugs, 2.2 (0—20) OTCs, and 1.9 (0—11) supplements. Twenty-one drugs were each taken by at least 10% of the subjects. Acetaminophen was taken by 59.6% of the subjects. One subject reported taking five acetaminophen-containing drugs. The questionnaire's sensitivity was 92.0%, specificity 99.9%.Conclusion. Within 3 days prior to chemotherapy, subjects took an average of 9.6 concomitant medications, many of which alter drug metabolism and or disposition. In clinical trials, multivariate analysis of all concomitant medications could add to clinically relevant data to identify drug interactions that negate or potentiate the efficacy of cancer treatment regimens. In some instances, apparent resistance of tumors to chemotherapy may be the result of drug interactions. J Oncol Pharm Practice (2008) 14: 123—130.Keywords
This publication has 26 references indexed in Scilit:
- Potential Drug Interactions and Duplicate Prescriptions Among Cancer PatientsJNCI Journal of the National Cancer Institute, 2007
- Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective studyHepatology, 2005
- Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary cultureJournal of Inorganic Biochemistry, 2005
- Sensitivity and specificity of self-reported use of dietary supplementsEuropean Journal of Clinical Nutrition, 2004
- Potential of chemotherapy?herb interactions in adult cancer patientsSupportive Care in Cancer, 2004
- An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast MalignanciesJournal of Clinical Oncology, 2004
- A Population-Based Survey of Complementary and Alternative Medicine Use in Men Recently Diagnosed with Prostate CancerIntegrative Cancer Therapies, 2003
- Use of herbs in women diagnosed with ovarian tcancerInternational Journal of Gynecologic Cancer, 2002
- Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish populationClinical Nutrition, 2001
- Sensitivity and specificity for correlated observationsStatistics in Medicine, 1992